Developing a Successful Grant Application

This episode of the NIH All About Grants podcast explores language access for participants in NIH supported clinical research. Ms. Melissa McGowan, the Deputy Director of the Office of Clinical Research within the National Institute on Aging’s Division of Extramural Activities, and Ms. Dawn Corbett, NIH’s Inclusion Policy Officer, will explain how to consider language access when proposing research in a grant application.

Milestone driven awards allow NIH to support riskier biomedical research projects. Unlike traditional research project grants many researchers may be familiar with, these awards have interim check-points (also referred to as “phases”) where progress towards achieving the objectives of the award are assessed.

Institutional training grants help prepare undergraduates, predoctoral students and postdoctoral scholars for careers in biomedical and behavioral research. Part 1 of this NIH All About Grants podcast miniseries dives into considerations for developing training grant applications and the review process, and part 2 focuses on post-award monitoring, mentorship, and provides insights for trainees.

In this NIH All About Grants podcast episode, we share advice for investigators to help them understand the critiques of their application, and how program staff input may be helpful when deciding what to do next. Drs.

A fundamental part of one’s growth as a researcher is understanding how scientific investigation is practiced with integrity, and knowing when and how to apply professional norms and ethical principles throughout the research process. To promote research integrity, NIH-supported trainees, fellows, participants, and scholars must receive instruction in the responsible conduct of research (RCR).

NIH’s definition of a Phase III clinical trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trails that compare two or more interventions against other standard or experimental interventions.

NIH expects that sex as a biological variable (SABV) will be factored into research designs, analyses, and reporting in pre-clinical and clinical studies. Accounting for SABV helps interpret and validate research findings, as well as enhances the rigor, reproducibility, and applicability of biomedical research. But how exactly do you account for SABV?

You may have heard that NIH can provide limited, interim research support for applications with creative and innovative approaches that fell just outside the payline. These “bridge awards” are helpful for researchers to gather additional data to revise their current application. But, how do we decide on which applications to support this way?

As of April 12, 2022, applicants seeking support for their scientific conference are required to submit a plan that promotes a Safe and respectful Environment as part of Just-In-Time materials should the application be recommended for funding (NOT-OD-22-074).